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A B ST R A C T
Dynam ic assessm ent o f  66 patients with different brain tum ours was carried out. The clinical, im m unological 
and instrum ental (electrophysiological and neuroim aging) follow-up included three groups o f cases with sta­
ble clinical course, tum our progression and recurrence. Our results confirm that the changes in the functional 
and im m une status o f  the patients with cerebral neoplasms as well as the alterations in the cerebral function 
and structure reflect the tum our developm ent and the corresponding therapeutic behaviour. M onitoring o f  
patients status and tum our growth provides opportunity for better disease control and prognosis.
K ey w ords: brain tum ours, clinical perform ance score, brain im aging, electrophysiology, im m une status
According to modem epidemiological data brain tumours 
are characterized with increasing rate o f morbidity and rela­
tively insufficient therapeutic efficacy, especially concern­
ing the most malignant forms (13). Their clinical picture 
presents with continuous progression o f  signs and symp­
toms as a result of local compression, destruction and dislo­
cation o f brain tissue and development o f intracranial hy­
pertension (2). The expansive or infiltrative tumour growth 
induces not only CNS structural and functional disorders
(4,5,15) but also abnormalities in immune and performance 
status o f the patients (1,3,6,11). This is the reason the com­
bined clinical, instrumental (computed tomography - CT, 
electroencephalography - EEG, and brain mapping - BM) 
and immunological follow-up through the course o f tumour 
progression to become a necessary condition for the early 
prediction o f recurrence, progression or malignization and 
the corresponding adequate treatment (8,10,14).
The aim o f the study was to dynamically assess the clinical, 
instrumental and immunological characteristics o f patients 
with brain tumours in relation to the various clinical course 
o f the disease.
with high-grade gliomas (astrocytomas gr. Ill and 
glioblastomas). Histopathological verification confirmed 
the diagnosis in all cases. Tumour classification and grada­
tion was carried out according to the recommendations of 
the World Health Organization (7). Preoperative and post­
operative (on 2, 6, 12, 18 and 24 months) follow-up in­
cluded: evaluation o f patient's functional status by 
Kamofsky index o f  performance status (KFS) (score from 
0 to 100); electrophysiological (EEG and BM) and CT 
studies and assessment of immunological status (lysozyme 
activity in serum by Zucker-Elliot, macrophage activity by 
NBT test, leukocyte count, B-lymphocyte and 
T-lymphocyte counts, T-h and T-s by Shore, T-h/T-s index 
and mitochondrial enzymes SDH and a-GPDH). All these 
immunological indices were compared to the values o f 30 
healthy controls. The correlative analysis between each pa­
tient brain maps and the maps o f controls was performed by 
means o f programmed Z score.
R E SU L T S A N D  D ISC U SSIO N
M A T E R IA L  A N D  M E T H O D S
A total o f 66 patients with different brain tumours diag­
nosed and followed-up in the Clinics o f Neurology and 
Neurosurgery o f Prof. Paraskev Stoyanov Medical Univer­
sity o f Varna were studied from 1995 to 2003. All cases 
were divided into 3 groups: I - 25 with meningiomas, 11-14 
with low-grade gliomas (astrocytomas gr. I-И), and III - 27
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In all the cases without recurrence and tumour progression 
(24 patients from group I and group II) the dynamic clinical 
examination showed reduction o f focal and common cere­
bral neurological deficit in the postoperative period (2 and 6 
months) and elevation o f the initial values o f KPS index. 
The parallel postoperative CT, EEG, and BM studies con­
firmed the reduction o f tumour mass and cerebral edema 
presenting on EEG records with decrease in slow-wave ac­
tivity and appearance o f focal limited delta and theta fluctu­
ations over the zone o f the pathological process. The post­
operative assessment o f immune status after 2 and 6 months 
outlined a gradual normalization o f the examined immuno­
logical parameters. Patients' follow-up expressed on 24 
month the same tendencies: elevation o f Kamofsky score
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(up to 70) in correlation to the recovery o f neurological def- data confirming the clinical course o f  the disease (lack of
icit, normalization o f the immunological parameters, CT tumour relapse and progression) and normalization of
C ase 1. L ow  g ra d e  astrocytom a. P re - a n d  p o sto p era tiv e  CT, E E G  a n d  B M  stu dy
Uroflowmetiy and ultrasound measurement o f residual urine in early Parkinson's disease 
C ase 2. A n aplastic  astrocytom a. P re - an d  p o sto p era tive  CT, E E G  an d  B M  study.
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C lin ic a l ,  in s t ru m e n ta l  a n d  im m u n o lo g ic a l  f o l lo w -u p  o f  p a t ie n ts  w i th  b ra in  tu m o rs
bioelectrical cerebral activity on the control EEG records 
(Clinical case 1).
The early postoperative period o f patients with tumour pro­
gression (a total o f 23 cases from group III) presented with 
slight elevation of KPS as a result o f tumour mass and 
edema reduction and values of immune indices closer to the 
initial ones. The control CT scans showed partial reduction 
of tumour burden, brain edema and dislocation phenomena 
EEG registered decrease o f the diffuse slow-wave activity. 
The follow-up of patients with tumour progression demon­
strated tendencies of decreasing Kamofsky score (under 
40), data o f continuing intensifying immunosuppression, 
CT images continuing tumour and edema progression and 
EEG records presenting with elevation o f diffuse 
slow-wave activity (Clinical case 2).
Patients with recurrent tumours (6 cases from group 1, 5 
from group II and 8 from group III) demonstrated initial 
postoperative improvement of KPS and the immune status 
indices. CT and EEG (reduction o f the common cerebral 
disorders with underlining o f the focal slow-wave activity) 
data reflected the primary tumour resection and the de­
crease of brain edem a The consequent worsening of the 
neurological deficit with decrease o f Kamofsky score and 
EEG records expressing a well defined pathological focus 
showed coincidence with the CT scans presenting tumour 
recurrence and the indices o f repeated immune suppression 
(Clinical case 3).
It is known that cerebral neoplasms with infiltrative or ex­
pansive growth can cause different focal and common clin­
ical signs, produce cerebral edema, destruction and disloca­
tion phenomena and provoke a broad immune suppression
(2,4,5,6,15). According to the literature available (8,10,14) 
the isolated or combined clinical, instrumental and immu­
nological follow-up o f patients with different brain 
neoplasms provides evidence that reflects the clinical 
course o f tumour development (stable, progressive, or re­
current). Patients with stable clinical course present with 
improvement of functional and immune status as well as 
with CT and EEG data confirming the tumour and edema 
reduction. The cases with progression of the disease show 
further worsening o f the functional status and continuing 
immune suppression (1) parallelly to the 
electrophysiological (9,14) and neuroimaging data o f tu­
mour progression. The postoperative control o f the patients 
with recurrent tumours demonstrates initial improvement 
o f their status followed by repeated worsening o f the clini­
cal, immunological, CT and EEG parameters as a result o f a 
new neoplasm growth. All these results (3,8,10,14) present 
evidence that the dynamic assessment o f clinical and im­
mune status o f the patients along with the detection o f func­
tional and structural cerebral damages may be an important 
tool enabling the precise diagnosis and the correct therapeu­
tic behaviour in the different phases of the neoplastic pro­
cess.
C O N C L U SIO N
Our study demonstrates the possible clinical benefit o f  the 
complex clinical, instrumental and immunological moni­
toring as a real opportunity for a dynamic assessment o f  pa­
tients with brain tumours in relation to the disease control 
and prognosis.
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